Phathom Pharmaceuticals, Inc. (PHAT)
10.85
-0.25
(-2.25%)
USD |
NASDAQ |
May 27, 15:51
Phathom Pharmaceuticals Free Cash Flow : -97.76M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals, Inc. | 182.81M |
| Ligand Pharmaceuticals, Inc. | 114.06M |
| Axsome Therapeutics, Inc. | -70.99M |
| Corcept Therapeutics, Inc. | 119.79M |
| Assertio Holdings, Inc. | -7.081M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.65M |
| Cash from Investing (Quarterly) | -0.061M |
| Cash from Financing (Quarterly) | 66.64M |
| Free Cash Flow Per Share (Quarterly) | -0.1914 |
| Free Cash Flow to Equity (Quarterly) | 26.25M |
| Free Cash Flow to Firm (Quarterly) | 0.089M |
| Free Cash Flow Yield | -11.95% |